Filing Details
- Accession Number:
- 0001140361-15-010609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-05 20:20:12
- Reporting Period:
- 2015-03-03
- Filing Date:
- 2015-03-05
- Accepted Time:
- 2015-03-05 20:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-03 | 39,600 | $0.00 | 254,757 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2015-03-05 | 10,000 | $12.99 | 52,279 | No | 4 | M | Indirect | Shares held by Bienaime Family Trust |
Common Stock | Disposition | 2015-03-05 | 10,000 | $113.70 | 42,279 | No | 4 | S | Indirect | Shares held by Bienaime Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Indirect | Shares held by Bienaime Family Trust |
No | 4 | S | Indirect | Shares held by Bienaime Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) Common Stock | Acquisiton | 2015-03-03 | 90,500 | $0.00 | 90,500 | $108.36 |
Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2015-03-05 | 10,000 | $0.00 | 10,000 | $12.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
90,500 | 2015-09-03 | 2025-03-02 | No | 4 | A | Direct |
51,500 | 2006-11-11 | 2016-05-10 | No | 4 | M | Indirect |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy Common Stock) | $12.99 | 2006-11-11 | 2016-05-10 | 10,000 | 10,000 | Indirect |
Common Stock | Stock Option (right to buy Common Stock) | $12.99 | 2006-11-11 | 2016-05-10 | 10,000 | 10,000 | Indirect |
Common Stock | Stock Option (right to buy Common Stock) | $12.99 | 2006-11-11 | 2016-05-10 | 10,000 | 10,000 | Indirect |
Common Stock | Stock Option (right to buy Common Stock) | $12.99 | 2006-11-11 | 2016-05-10 | 10,000 | 10,000 | Indirect |
Common Stock | Stock Option (right to buy Common Stock) | $12.99 | 2006-11-11 | 2016-05-10 | 20,000 | 20,000 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-05-10 | 10,000 | 10,000 | Indirect |
2016-05-10 | 10,000 | 10,000 | Indirect |
2016-05-10 | 10,000 | 10,000 | Indirect |
2016-05-10 | 10,000 | 10,000 | Indirect |
2016-05-10 | 20,000 | 20,000 | Indirect |
Footnotes
- Restricted stock units granted on March 3, 2015. Price not applicable.
- The reporting person an his spouse act as trustees for the Bienaime Family Trust
- The price in column 4 is an average weighted price. The price actually received ranged from $113.27 to $114.00. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter
- Original option grant vests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.
- The reporting person's spouse is the trustee of each child's trust.